Effect of strontium on bone histomorphometric parameters in haemodialysis patients;Efecto del estroncio sobre el metabolismo óseo en pacientes en hemodiálisis

Nefrologia

Volumn 23, Issue SUPPL.2, 2003, Pages 52-56

  Gerstenfeld, S ^a   Hinojosa, L ^b   Serrano Arias, M ^a   Menendez Rodriguez P ^a   Fernandez Martin J L ^a   Marchante, J M ^b   Garcia Alonso J I ^b   Sanz Medel, A ^b   Cannata Andia J B ^a  

^a HOSPITAL UNIVERSITARIO CENTRAL DE ASTURIAS   (Spain)

^b UNIVERSITY OF OVIEDO   (Spain)

Author keywords

Osteomalacia; Renal osteodystrophy; Strontium

Indexed keywords

ALKALINE PHOSPHATASE; CALCIUM; HEMODIALYSIS FLUID; PARATHYROID HORMONE; STRONTIUM;

ARGENTINA; ARTICLE; BIOPSY; BLOOD; BONE; CHEMICALLY INDUCED DISORDER; CHEMISTRY; CHRONIC KIDNEY FAILURE; HUMAN; ILIAC BONE; METABOLISM; OSTEOMALACIA; PATHOLOGY; PORTUGAL; RENAL OSTEODYSTROPHY; RENAL REPLACEMENT THERAPY; SECONDARY HYPERPARATHYROIDISM; SPAIN;

ALKALINE PHOSPHATASE; ARGENTINA; BIOPSY; BONE AND BONES; CALCIUM; HEMODIALYSIS SOLUTIONS; HUMANS; HYPERPARATHYROIDISM, SECONDARY; ILIUM; KIDNEY FAILURE, CHRONIC; OSTEOMALACIA; PARATHYROID HORMONE; PORTUGAL; RENAL DIALYSIS; RENAL OSTEODYSTROPHY; SPAIN; STRONTIUM;

EID: 0038334299     PISSN: 02116995     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (12)

1. Cohen-Solal M Strontium overload and toxicity: impact on renal osteodystrophy. Nephrol Dial Transplant 17 (Supl. 2): 30-34, 2002.
2. Schrooten I, Elseviers MM, Lamberts LV, De Broe ME, D'Haese PC Increased serum strontium levels in dialysis patients: an epidemiological survey. Kidney Int 56: 1886-1892, 1999.
3. Múniz CS, Fernández-Martín JL, Marchante-Gayón JM, García Alonso JI, Cannata-Andía JB, Sanz-Medel A Reference values for trace and ultratrace elements in human serum determined by double-focusing ICP-MS. Biol Trace Elem Res 82: 259-272, 2001.
4. Vanholder R, Cornelis R, Dhondt A, Lameire N The role of trace elements in uraemic toxicity. Nephrol Dial Transplant 17 (Supl. 2): 2-8, 2002.
5. D'Haese PC, Schrooten I, Goodman WG, Cabrera WE, Lamberts LV, Elseviers MM, Couttenye MM, De Broe ME Increased bone strontium levels in hemodialysis patients with osteomalacia. Kidney Int 57: 1107-1114, 2000.
6. Schrooten I, Cabrera W, Goodman WG, Dauwe S, Lamberts LV, Marynissen R, Dorrine W, De Broe ME, D'Haese PC: Strontium causes osteomalacia in chronic renal failure rats. Kidney Int 54: 448-456, 1998.
7. Cohen-Solal ME, Augry F, Mauras Y, Morieux C, Allain P, De Vernejoul MC.: Fluoride and strontium accumulation in bone does not correlate with osteoid tissue in dialysis patients. Nephrol Dial Transplant 17: 449-454, 2002.
8. Cannata JB, Fernández-Soto I, Fernández-Menéndez MJ, Fernández-Martín JL, McGregor SJ, Brock JH, Halls D.: Role of iron metabolism in absorption and cellular uptake of aluminum. Kidney Int 39: 799-803, 1991.
9. Zima T, Mestek O, Nemecek K, Bartova V, Fialova J, Tesar V, Suchanek M.: Trace elements in hemodialysis and continuous ambulatory peritoneal dialysis patients. Blood Purif 16: 253-260, 1998.
10. Smythe WR, Alfrey AC, Craswell PW, Crouch CA, Ibels LS, Kubo H, Nunnelley LL, Rudolph H. Trace element abnormalities in chronic uremia. Ann Intern Med 96: 302-310, 1982.
11. Hosokawa S, Yoshida O. Clinical studies on molybdenum in patients requiring long-term hemodialysis. Asaio J 40: M445-449, 1994.
12. D'Haese PC, Couttenye MM, Lamberts LV, Elseviers MM, Goodman WG, Schrooten I, Cabrera WE, De Broe ME. Aluminum, iron, lead, cadmium, copper, zinc, chromium, magnesium, strontium, and calcium content in bone of end-stage renal failure patients. Clin Chem 45: 1548-1556, 1999.